Clinical Trial Results:
A Randomized, Double-Blind, Multi-center, Phase II Fixed Dose Study of Multiple Doses of Ipilimumab (MDX-010) Monotherapy in Patients with Previously Treated Unresectable Stage III or IV Melanoma
Revised Protocol 1, incorporating Amendment 2 - version 4.0, dated 15-Feb-06
Summary
|
|
EudraCT number |
2005-003265-16 |
Trial protocol |
BE GB DE CZ |
Global completion date |
15 May 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
24 Dec 2016
|
First version publication date |
24 Dec 2016
|
Other versions |
|
Summary report(s) |
CA184-022_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.